Using Epidemiology and Genomics to Understand Osteosarcoma Etiology

Sarcoma · 2011 · Classic · cited 323 times

Sharon A. Savage, Lisa Mirabello

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute

Orthopaedic Oncology

SUMMARY — THE REDUCTIONThis review discusses osteosarcoma's poorly understood etiology, examining epidemiologic risk factors (Paget disease, radiation, height) and emerging genomic associations without identifying a strong environmental cause.
Abstract, as published

Osteosarcoma is a primary bone malignancy that typically occurs during adolescence but also has a second incidence peak in the elderly. It occurs most commonly in the long bones, although there is variability in location between age groups. The etiology of osteosarcoma is not well understood; it occurs at increased rates in individuals with Paget disease of bone, after therapeutic radiation, and in certain cancer predisposition syndromes. It also occurs more commonly in taller individuals, but a strong environmental component to osteosarcoma risk has not been identified. Several studies suggest that osteosarcoma may be associated with single nucleotide polymorphisms in genes important in growth and tumor suppression but the studies are limited by sample size. Herein, we review the epidemiology of osteosarcoma as well as its known and suspected risk factors in an effort to gain insight into its etiology.

Featured in the 2026-08-09 issue.

← Comparing Human and AI-Generated Editorials in Orthopaedic On…Histology-Tailored Approach to Soft Tissue Sarcoma. →

The Reduction is a free email digest of newly published orthopaedic literature — a handful of new papers in the subspecialties you choose, each summarized like this one. Subscribe free or browse the archive.